Federico Ávila‐Moreno

1.0k total citations
35 papers, 639 citations indexed

About

Federico Ávila‐Moreno is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Federico Ávila‐Moreno has authored 35 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Immunology. Recurrent topics in Federico Ávila‐Moreno's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (5 papers) and Epigenetics and DNA Methylation (4 papers). Federico Ávila‐Moreno is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (5 papers) and Epigenetics and DNA Methylation (4 papers). Federico Ávila‐Moreno collaborates with scholars based in Mexico, United States and Colombia. Federico Ávila‐Moreno's co-authors include Óscar Arrieta, Joaquı́n Zúñiga, Blanca Ortíz-Quintero, Alfredo Hidalgo‐Miranda, Patricia Piña‐Sánchez, Cynthia Villarreal‐Garza, Carmen Sánchez‐Torres, José Sullivan López-González, Heriberto Prado-Garcı́a and Carlos Pérez‐Plasencia and has published in prestigious journals such as Molecular and Cellular Biology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Federico Ávila‐Moreno

33 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Ávila‐Moreno Mexico 17 373 218 160 156 100 35 639
Géraldine Rios France 8 289 0.8× 212 1.0× 71 0.4× 154 1.0× 96 1.0× 10 548
Julie M. Lowe United States 10 362 1.0× 142 0.7× 211 1.3× 151 1.0× 30 0.3× 11 581
Ariel Ramírez-Labrada Spain 15 325 0.9× 70 0.3× 293 1.8× 296 1.9× 96 1.0× 28 740
Weiming Zhao China 17 459 1.2× 152 0.7× 136 0.8× 124 0.8× 55 0.6× 43 761
Xinhong Pei China 12 291 0.8× 131 0.6× 77 0.5× 97 0.6× 57 0.6× 21 595
Magdalena Frydrychowicz Poland 9 229 0.6× 135 0.6× 98 0.6× 117 0.8× 54 0.5× 25 438
Joshua J. Thompson United States 12 269 0.7× 74 0.3× 87 0.5× 65 0.4× 41 0.4× 24 424
Sonja Thaler Germany 14 274 0.7× 70 0.3× 162 1.0× 103 0.7× 47 0.5× 25 542

Countries citing papers authored by Federico Ávila‐Moreno

Since Specialization
Citations

This map shows the geographic impact of Federico Ávila‐Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Ávila‐Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Ávila‐Moreno more than expected).

Fields of papers citing papers by Federico Ávila‐Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Ávila‐Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Ávila‐Moreno. The network helps show where Federico Ávila‐Moreno may publish in the future.

Co-authorship network of co-authors of Federico Ávila‐Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Ávila‐Moreno. A scholar is included among the top collaborators of Federico Ávila‐Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Ávila‐Moreno. Federico Ávila‐Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gutiérrez, Humberto, Humberto Garcia‐Ortíz, Lorena Orozco, et al.. (2025). A Pilot Study: Contrasting Genomic Profiles of Lung Adenocarcinoma Between Patients of European and Latin American Ancestry. International Journal of Molecular Sciences. 26(10). 4865–4865.
3.
Escobedo, Galileo, et al.. (2024). Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells. Inflammation. 47(6). 2159–2172. 4 indexed citations
4.
Villamar‐Cruz, Olga, Marco A. Loza-Mejía, Genaro Patiño‐López, et al.. (2023). A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway. Molecular and Cellular Biology. 43(12). 631–649. 1 indexed citations
5.
Ledesma‐Soto, Yadira, et al.. (2023). STAT6 controls the stability and suppressive function of regulatory T cells. European Journal of Immunology. 53(5). e2250128–e2250128. 6 indexed citations
6.
Barrios‐Bernal, Pedro, Zyanya Lucía Zatarain-Barrón, Norma Hernández‐Pedro, et al.. (2022). Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. Pharmaceuticals. 15(7). 786–786. 8 indexed citations
7.
Rodríguez‐Cruz, Maricela, et al.. (2022). Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters. Acta Neurologica Scandinavica. 146(5). 512–524. 5 indexed citations
8.
Mejía‐Domínguez, Nancy R., Felipe Vaca‐Paniagua, Federico Ávila‐Moreno, et al.. (2022). Variability in Susceptibility to Type I Interferon Response and Subgenomic RNA Accumulation Between Clinical Isolates of Dengue and Zika Virus From Oaxaca Mexico Correlate With Replication Efficiency in Human Cells and Disease Severity. Frontiers in Cellular and Infection Microbiology. 12. 890750–890750. 3 indexed citations
9.
Mendoza-Milla, Criselda, et al.. (2020). LncRNA SOX2‐OT regulates AKT/ERK and SOX2/GLI‐1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases. Molecular Oncology. 15(4). 1110–1129. 36 indexed citations
10.
Orozco‐Morales, Mario, et al.. (2020). CD47‐SIRP α Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer. Journal of Immunology Research. 2020(1). 9435030–9435030. 28 indexed citations
11.
Zúñiga, Joaquı́n, et al.. (2019). Epigenetics in non-small cell lung carcinomas. Salud Pública de México. 61(3, may-jun). 318–318. 6 indexed citations
12.
Soca‐Chafre, Giovanny, Norma Hernández‐Pedro, Alejandro Avilés‐Salas, et al.. (2018). Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients. Oncotarget. 9(55). 30499–30512. 7 indexed citations
13.
León‐Cabrera, Sonia, Yadira Ledesma‐Soto, Carlos Pérez‐Plasencia, et al.. (2017). Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer. Cancer Immunology Research. 5(5). 385–396. 46 indexed citations
14.
Krötzsch, Edgar, Luis Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.. (2014). Serum Surfactant Protein D (SP-D) is a Prognostic Marker of Poor Outcome in Patients with A/H1N1 Virus Infection. Lung. 193(1). 25–30. 21 indexed citations
15.
León‐Cabrera, Sonia, Blanca E. Callejas, Yadira Ledesma‐Soto, et al.. (2014). Extraintestinal Helminth Infection Reduces the Development of Colitis-Associated Tumorigenesis. International Journal of Biological Sciences. 10(9). 948–956. 30 indexed citations
16.
Jiménez-Álvarez, Luis, Gustavo Ramírez-Martínez, Blanca Ortíz-Quintero, et al.. (2011). The effect of CTLA-4Ig, a CD28/B7 antagonist, on the lung inflammation and T cell subset profile during murine hypersensitivity pneumonitis. Experimental and Molecular Pathology. 91(3). 718–722. 15 indexed citations
17.
Zenteno, Edgar, Federico Ávila‐Moreno, Francisco Javier Sánchez‐García, et al.. (2010). Amaranthus leucocarpuslectin (ALL) Enhances anti-CD3-Dependent Activation of Murine T Cells and Promotes Cell Survival. Immunological Investigations. 40(2). 113–129. 6 indexed citations
18.
López-González, José Sullivan, Federico Ávila‐Moreno, Heriberto Prado-Garcı́a, et al.. (2006). Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-α. Clinical Immunology. 122(3). 323–329. 18 indexed citations
19.
Ávila‐Moreno, Federico, José Sullivan López-González, Griselda Galindo-Rodrı́guez, et al.. (2005). Lung squamous cell carcinoma and adenocarcinoma cell lines use different mediators to induce comparable phenotypic and functional changes in human monocyte-derived dendritic cells. Cancer Immunology Immunotherapy. 55(5). 598–611. 19 indexed citations
20.
López-González, José Sullivan, Dolores Aguilar‐Cázares, Heriberto Prado-Garcı́a, et al.. (2002). Lack of correlation between growth inhibition by TGF-β and the percentage of cells expressing type II TGF-β receptor in human non-small cell lung carcinoma cell lines. Lung Cancer. 38(2). 149–158. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Géraldine Rios Breakdown of academic impact, for papers by Julie M. Lowe Breakdown of academic impact, for papers by Ariel Ramírez-Labrada Breakdown of academic impact, for papers by Weiming Zhao Breakdown of academic impact, for papers by Xinhong Pei Breakdown of academic impact, for papers by Magdalena Frydrychowicz Breakdown of academic impact, for papers by Joshua J. Thompson Breakdown of academic impact, for papers by Sonja Thaler
Rankless by CCL
2026